Prophase Labs Inc is a biotechnology company focused on developing and commercializing innovative healthcare solutions, particularly in the fields of over-the-counter pharmaceuticals and medical devices
The company leverages its expertise in scientific research and product development to create high-quality consumer health products aimed at improving patient outcomes. Prophase Labs is dedicated to advancing health and wellness through its commitment to safety, efficacy, and accessibility, while actively pursuing opportunities in both established and emerging markets to expand its portfolio and reach.
ProPhase Labs shares are trading lower by 50% during Friday's session. The company announced a 4.17 million share offering at 72 cents per share, totaling $3 million.
DSS Wealth, Inc. has appointed Daniel Lew as its new Chief Investment Officer (CIO) and Portfolio Manager. DSS Wealth is a mutual fund and a wholly-owned subsidiary of DSS, Inc.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQIDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
